1026 related articles for article (PubMed ID: 18074465)
1. Polyclonal intravenous immunoglobulin for the treatment of severe sepsis and septic shock in critically ill adults: a systematic review and meta-analysis.
Laupland KB; Kirkpatrick AW; Delaney A
Crit Care Med; 2007 Dec; 35(12):2686-92. PubMed ID: 18074465
[TBL] [Abstract][Full Text] [Related]
2. Clinical experience with polyclonal IgM-enriched immunoglobulins in a group of patients affected by sepsis after cardiac surgery.
Buda S; Riefolo A; Biscione R; Goretti E; Cattabriga I; Grillone G; Bacchi-Reggiani L; Pacini D
J Cardiothorac Vasc Anesth; 2005 Aug; 19(4):440-5. PubMed ID: 16085247
[TBL] [Abstract][Full Text] [Related]
3. IgMA-enriched immunoglobulin in neutropenic patients with sepsis syndrome and septic shock: a randomized, controlled, multiple-center trial.
Hentrich M; Fehnle K; Ostermann H; Kienast J; Cornely O; Salat C; Ubelacker R; Buchheidt D; Behre G; Hiddemann W; Schiel X
Crit Care Med; 2006 May; 34(5):1319-25. PubMed ID: 16540956
[TBL] [Abstract][Full Text] [Related]
4. Use of polyclonal immunoglobulins as adjunctive therapy for sepsis or septic shock.
Kreymann KG; de Heer G; Nierhaus A; Kluge S
Crit Care Med; 2007 Dec; 35(12):2677-85. PubMed ID: 18074464
[TBL] [Abstract][Full Text] [Related]
5. Intravenous polyclonal IgM-enriched immunoglobulin therapy in sepsis: a review of clinical efficacy in relation to microbiological aetiology and severity of sepsis.
Norrby-Teglund A; Haque KN; Hammarström L
J Intern Med; 2006 Dec; 260(6):509-16. PubMed ID: 17116001
[TBL] [Abstract][Full Text] [Related]
6. Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock.
Alejandria MM; Lansang MA; Dans LF; Mantaring JB
Cochrane Database Syst Rev; 2013 Sep; 2013(9):CD001090. PubMed ID: 24043371
[TBL] [Abstract][Full Text] [Related]
7. Time- and fluid-sensitive resuscitation for hemodynamic support of children in septic shock: barriers to the implementation of the American College of Critical Care Medicine/Pediatric Advanced Life Support Guidelines in a pediatric intensive care unit in a developing world.
Oliveira CF; Nogueira de Sá FR; Oliveira DS; Gottschald AF; Moura JD; Shibata AR; Troster EJ; Vaz FA; Carcillo JA
Pediatr Emerg Care; 2008 Dec; 24(12):810-5. PubMed ID: 19050666
[TBL] [Abstract][Full Text] [Related]
8. Intravenous immunoglobulin for treating sepsis and septic shock.
Alejandria MM; Lansang MA; Dans LF; Mantaring JB
Cochrane Database Syst Rev; 2002; (1):CD001090. PubMed ID: 11869591
[TBL] [Abstract][Full Text] [Related]
9. An evaluation of the feasibility, cost and value of information of a multicentre randomised controlled trial of intravenous immunoglobulin for sepsis (severe sepsis and septic shock): incorporating a systematic review, meta-analysis and value of information analysis.
Soares MO; Welton NJ; Harrison DA; Peura P; Shankar- Hari M; Harvey SE; Madan JJ; Ades AE; Palmer SJ; Rowan KM
Health Technol Assess; 2012; 16(7):1-186. PubMed ID: 22361003
[TBL] [Abstract][Full Text] [Related]
10. To use or not to use? Polyclonal intravenous immunoglobulins for the treatment of sepsis and septic shock.
Neugebauer EA
Crit Care Med; 2007 Dec; 35(12):2855-6. PubMed ID: 18043203
[No Abstract] [Full Text] [Related]
11. Meta-analysis: intravenous immunoglobulin in critically ill adult patients with sepsis.
Turgeon AF; Hutton B; Fergusson DA; McIntyre L; Tinmouth AA; Cameron DW; Hébert PC
Ann Intern Med; 2007 Feb; 146(3):193-203. PubMed ID: 17283351
[TBL] [Abstract][Full Text] [Related]
12. Polyclonal intravenous immunoglobulin: an important additional strategy in sepsis?
Di Rosa R; Pietrosanti M; Luzi G; Salemi S; D'Amelio R
Eur J Intern Med; 2014 Jul; 25(6):511-6. PubMed ID: 24877856
[TBL] [Abstract][Full Text] [Related]
13. Alcohol dependence is independently associated with sepsis, septic shock, and hospital mortality among adult intensive care unit patients.
O'Brien JM; Lu B; Ali NA; Martin GS; Aberegg SK; Marsh CB; Lemeshow S; Douglas IS
Crit Care Med; 2007 Feb; 35(2):345-50. PubMed ID: 17205003
[TBL] [Abstract][Full Text] [Related]
14. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
Sobieraj DM; White CM; Coleman CI
Clin Ther; 2008 Aug; 30(8):1416-25. PubMed ID: 18803985
[TBL] [Abstract][Full Text] [Related]
15. Intravenous immunoglobulin for treating sepsis and septic shock.
Alejandria MM; Lansang MA; Dans LF; Mantaring JB
Cochrane Database Syst Rev; 2001; (2):CD001090. PubMed ID: 11405973
[TBL] [Abstract][Full Text] [Related]
16. The Effect of Early Goal-Directed Therapy on Outcome in Adult Severe Sepsis and Septic Shock Patients: A Meta-Analysis of Randomized Clinical Trials.
Xu JY; Chen QH; Liu SQ; Pan C; Xu XP; Han JB; Xie JF; Huang YZ; Guo FM; Yang Y; Qiu HB
Anesth Analg; 2016 Aug; 123(2):371-81. PubMed ID: 27049857
[TBL] [Abstract][Full Text] [Related]
17. Role of corticosteroids in septic shock.
Burry LD; Wax RS
Ann Pharmacother; 2004 Mar; 38(3):464-72. PubMed ID: 14970369
[TBL] [Abstract][Full Text] [Related]
18. Mirror, mirror on the wall, which is the fairest meta-analysis of all?
Werdan K
Crit Care Med; 2007 Dec; 35(12):2852-4. PubMed ID: 18043202
[No Abstract] [Full Text] [Related]
19. [[Antithrombin III concentrates in the treatmetn of sepsis and septic shock: indictions, limits and future prospects] ].
Baudo F; de Cataldo F
Minerva Anestesiol; 2000 Nov; 66(11 Suppl 1):3-23. PubMed ID: 11213542
[TBL] [Abstract][Full Text] [Related]
20. Effect of initial corticosteroid therapy on coronary artery aneurysm formation in Kawasaki disease: a meta-analysis of 862 children.
Wooditch AC; Aronoff SC
Pediatrics; 2005 Oct; 116(4):989-95. PubMed ID: 16199713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
